CDK2 and breast carcinoma: While a specific E3 ubiquitin ligase called KLHL6 mediated the ubiquitin-dependent proteasome degradation of CDK2 in leukemia cells41, in breast cancer cells, β-transducing repeat–containing proteins (βTrCP) controlled the autophagic degradation of CDK142.